Phosphodiesterase-5 inhibitors (PDE5Is) have been shown to modulate cell death/cell survival in different in vivo and in vitro models of disease by activating many signaling pathways. This review aimed at elucidating how PDE5Is can inhibit apoptosis. In this study, we describe many signaling pathways involved with the mechanism of action of PDE5Is that ultimately inhibit apoptosis and thus promote cell survival.
Get full access to this article
View all access options for this article.
References
1.
AlirezaeiM., FoxH.S., FlynnC.T., MooreC.S., HebbA.L.O., FraustoR.F., et al. (2009). Elevated ATG5 expression in autoimmune demyelination and multiple sclerosis. Autophagy, 5, 152–158.
2.
BhattacharyaA., ParillonX., ZengS., HanS., and EissaN.T. (2014). Deficiency of autophagy in dendritic cells protects against experimental autoimmune encephalomyelitis. J Biol Chem, 289, 26525–26532.
3.
CianiE., VirgiliM., and ContestabileA. (2002). Akt pathway mediates a cGMP-dependent survival role of nitric oxide in cerebellar granule neurones. J Neurochem, 81, 218–228.
4.
DasguptaA., ZhengJ., and BizzozeroO.A. (2012). Protein carbonylation and aggregation precede neuronal apoptosis induced by partial glutathione depletion. ASN Neuro, 4, 161–174.
5.
DasguptaA., ZhengJ., Perrone-BizzozeroN.I., and BizzozeroO.A. (2013). Increased carbonylation, protein aggregation and apoptosis in the spinal cord of mice with experimental autoimmune encephalomyelitis. ASN Neuro, 5, e00111.
6.
DawsonT.M., and GintyD.D. (2002). CREB family transcription factors inhibit neuronal suicide. Nat Med, 8, 450–451.
7.
Duarte-SilvaE., AraújoS.M.D.R., OliveiraW.H., LósD.B., FrançaM.E.R., BonfantiA.P., et al. (2018). Sildenafil ameliorates EAE by decreasing apoptosis in the spinal cord of C57BL/6 mice. J Neuroimmunol, 321, 125–137.
8.
EstévezA.G., KamaidA., ThompsonJ.A., CornwellT.L., RadiR., BarbeitoL., et al. (2002). Cyclic guanosine 5′ monophosphate (GMP) prevents expression of neuronal nitric oxide synthase and apoptosis in motor neurons deprived of trophic factors in rats. Neurosci Lett, 326, 201–205.
9.
García-OstaA., Cuadrado-TejedorM., García-BarrosoC., OyarzábalJ., and FrancoR. (2012). Phosphodiesterases as therapeutic targets for Alzheimer's disease. ACS Chem Neurosci, 3, 832–844.
10.
GongW., DuanQ., CaiZ., ChenC., NiL., YanM., et al. (2013). Chronic inhibition of cGMP-specific phosphodiesterase 5 suppresses endoplasmic reticulum stress in heart failure. Br J Pharmacol, 170, 1396–1409.
11.
HaK.-S., KimK.-M., KwonY.-G., BaiS.-K., NamW.-D., YooY.-M., et al. (2003). Nitric oxide prevents 6-hydroxydopamine-induced apoptosis in PC12 cells through cGMP-dependent PI3 kinase/Akt activation. FASEB J, 17, 1036–1047.
12.
HetzC., and SaxenaS. (2017). ER stress and the unfolded protein response in neurodegeneration. Nat Rev Neurol, 13, 477–491.
13.
JeongS., SonY., LeeJ.H., ChoiS.W., KimS.H., CheongY., et al. (2017). Both nitric oxide and nitrite prevent homocysteine-induced endoplasmic reticulum stress and subsequent apoptosis via cGMP-dependent pathway in neuronal cells. Biochem Biophys Res Commun, 493, 164–169.
14.
KeynesR.G., and GarthwaiteJ. (2004). Nitric oxide and its role in ischaemic brain injury. Curr Mol Med, 4, 179–191.
15.
LiangP., and LeW., (2015). Role of autophagy in the pathogenesis of multiple sclerosis. Neurosci Bull, 31, 435–444.
16.
NakamizoT., KawamataJ., YoshidaK., KawaiY., KankiR., SawadaH., et al. (2003). Phosphodiesterase inhibitors are neuroprotective to cultured spinal motor neurons. J Neurosci Res, 71, 485–495.
17.
NapoliC., PaolissoG., CasamassimiA., Al-OmranM., BarbieriM., SommeseL., et al. (2013). Effects of nitric oxide on cell proliferation: novel insights. J Am Coll Cardiol, 62, 89–95.
18.
OrejanaL., Barros-MiñonesL., JordanJ., Cedazo-MinguezA., TorderaR.M., AguirreN., et al. (2015). Sildenafil decreases BACE1 and cathepsin B levels and reduces APP amyloidogenic processing in the SAMP8 mouse. J Gerontol A Biol Sci Med Sci, 70, 675–685.
19.
PuzzoD., LoretoC., GiuntaS., MusumeciG., FrascaG., PoddaM.V., et al. (2014). Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice. Neurobiol Aging, 35, 520–531.
20.
RanekM.J., TerpstraE.J.M., LiJ., KassD.A., and WangX. (2013). Protein kinase G positively regulates proteasome-mediated degradation of misfolded proteins. Circulation, 128, 365–376.
21.
RapôsoC., LunaR.L., deA., NunesA.K.S., ThoméR., and PeixotoC.A. (2014). Role of iNOS-NO-cGMP signaling in modulation of inflammatory and myelination processes. Brain Res Bull, 104, 60–73.
22.
TakumaK., PhuagphongP., LeeE., MoriK., BabaA., and MatsudaT. (2001). Anti-apoptotic effect of cGMP in cultured astrocytes: inhibition by cGMP-dependent protein kinase of mitochondrial permeable transition pore. J Biol Chem, 276, 48093–48099.
23.
ThomasD.D., RidnourL.A., IsenbergJ.S., Flores-SantanaW., SwitzerC.H., DonzelliS., et al. (2008). The chemical biology of nitric oxide: implications in cellular signaling. Free Radic Biol Med, 45, 18–31.
24.
WaltonM.R., and DragunowM. (2000). Is CREB a key to neuronal survival?. Trends Neurosci, 23, 48–53.
25.
WangL., and ZhuZ.A. (2014). Nitric oxide show its survival role by NO-PKC pathway through cGMP-dependent or independent on the culture of cerebella granular neurons. Neurosci Lett, 583, 165–169.
26.
WuD.J., and AdamopoulosI.E. (2017). Autophagy and autoimmunity. Clin Immunol, 176, 55–62.
27.
ZhangH., and WangX. (2015). Priming the proteasome by protein kinase G: a novel cardioprotective mechanism of sildenafil. Future Cardiol, 11, 177–189.
28.
ZhangJ., GuoJ., ZhaoX., ChenZ., WangG., LiuA., et al. (2013). Phosphodiesterase-5 inhibitor sildenafil prevents neuroinflammation, lowers beta-amyloid levels and improves cognitive performance in APP/PS1 transgenic mice. Behav Brain Res, 250, 230–237.
